Leg Ulcers and Lymphedema

  • Luciana Patrícia Fernandes AbbadeEmail author
  • Hélio Amante Miot


Leg ulcers are of major concern in public health because of their high prevalence (especially among older people), chronicity, economic burden, and impact on quality of life. Besides the need for primary prevention in susceptible groups, adequate etiologic diagnosis and a multispecialty approach can lead to successful treatment. Similarly, chronic lymphedema is a limiting disorder that predisposes to recurrent soft skin infection, leg ulcers, and malignancy. In this chapter we discuss clinical patterns, diagnostic procedures, and management of the main types of leg ulcers and lymphedema.


Leg ulcer Varicose ulcer Venous insufficiency Lymphedema Martorell’s ulcer Hypertensive ischemic ulcer Lower extremity ulcer 




Considered a type of panniculitis (inflammation of subcutaneous fat). Literally means “scarring of the skin and fat” and is a slow process that occurs over a number of years. It is a condition that affects the skin just above the ankle in patients with long-standing venous disease resulting in chronic venous insufficiency. The end result of untreated lipodermosclerosis is ulcer formation with high incidence of delayed healing and infection.


An abnormal collection of high-protein fluid just beneath the skin. It usually develops when lymph vessels are damaged or lymph nodes are removed (secondary lymphedema) but can also be present when lymphatic vessels are missing or impaired due to a hereditary condition (primary lymphedema).


Inflammation of the blood vessels. It causes changes in the walls of blood vessels, including thickening, weakening, narrowing, and scarring. These changes restrict blood flow, resulting in organ and tissue damage.


  1. 1.
    Agale SV. Chronic leg ulcers: epidemiology, aetiopathogenesis and management. Ulcers. 2013;2013:e1–9.CrossRefGoogle Scholar
  2. 2.
    Jockenhöfer F, Gollnick H, Herberger K, et al. Aetiology, comorbidities and cofactors of chronic leg ulcers: retrospective evaluation of 1 000 patients from 10 specialised dermatological wound care centers in Germany. Int Wound J. 2016;13(5):821–8.Google Scholar
  3. 3.
    Rabe E. Epidemiology of varicose veins. In: Phlebolymphology. 2010;17(1):19.Google Scholar
  4. 4.
    Park SH, Ferreira K, Santos VL. Understanding pain and quality of life for patients with chronic venous ulcers. Wounds Compend Clin Res Pract. 2008;20:309–20.Google Scholar
  5. 5.
    Lal BK. Venous ulcers of the lower extremity: definition, epidemiology, and economic and social burdens. Semin Vasc Surg. 2015;28:3–5.CrossRefPubMedGoogle Scholar
  6. 6.
    Donnell TFO Jr, Passman MA, Marston WA, et al. Management of venous leg ulcers: clinical practice guidelines of the society for vascular surgery Ò and the American Venous Forum. J Vasc Surg. 2014;60:3–59.CrossRefGoogle Scholar
  7. 7.
    Meissner MH. Venous ulcer care: which dressings are cost effective? Phlebol J Venous Dis. 2014;29:174–80.CrossRefGoogle Scholar
  8. 8.
    Wilkinson LS, Bunker C, Edwards JCW, Scurr JH, Smith PDC. Leukocytes: their role in the etiopathogenesis of skin damage in venous disease. J Vasc Surg. 1993;17:669–75.CrossRefPubMedGoogle Scholar
  9. 9.
    Liu YC, Margolis DJ, Isseroff RR. Does inflammation have a role in the pathogenesis of venous ulcers? A critical review of the evidence. J Invest Dermatol. 2011;131:818–27.CrossRefPubMedGoogle Scholar
  10. 10.
    Abbade LPF, Lastoria S, Rollo HDA. Venous ulcer: clinical characteristics and risk factors. Int J Dermatol. 2011;50:405–11.CrossRefPubMedGoogle Scholar
  11. 11.
    Zimmet SE. Venous leg ulcers: modern evaluation and management. Dermatol Surg. 1999;25:236–41.CrossRefPubMedGoogle Scholar
  12. 12.
    Beldon P. Avoiding allergic contact dermatitis in patients with venous leg ulcers. Br J Commun Nurs. 2006;11:S6. s8, s10–2CrossRefGoogle Scholar
  13. 13.
    Vowden P. Understanding the ankle brachial pressure index to treat venous ulceration. Wounds UK. 2012;8:10–5.Google Scholar
  14. 14.
    Malgor RD, Labropoulos N. Diagnosis of venous disease with duplex ultrasound. Phlebology. 2013;28:158–61.CrossRefPubMedGoogle Scholar
  15. 15.
    Souza JM, Vieira ÉC, Cortez TM, Mondelli AL, Miot HA, Abbade LPF. Clinical and microbiologic evaluation of chronic leg ulcers: a cross-sectional study. Adv Skin Wound Care. 2014;27:222–7.CrossRefPubMedGoogle Scholar
  16. 16.
    Stücker M, Link K, Reich-Schupke S, Altmeyer P, Doerler M. Compression and venous ulcers. Phlebology. 2013;28(Suppl 1):68–72.CrossRefPubMedGoogle Scholar
  17. 17.
    de Lima EL, Salome GM, Rocha M, Ferreira LM. The impact of compression therapy with Unna’s boot on the functional status of VLU patients. J Wound Care. 2013;22:558–61.CrossRefGoogle Scholar
  18. 18.
    Mauck KF, Asi N, Elraiyah TA, et al. Comparative systematic review and meta-analysis of compression modalities for the promotion of venous ulcer healing and reducing ulcer recurrence. J Vasc Surg. 2014;60:71s–90s.CrossRefPubMedGoogle Scholar
  19. 19.
    Raju S, Hollis K, Neglen P. Use of compression stockings in chronic venous disease: patient compliance and efficacy. Ann Vasc Surg. 2007;21:790–5.CrossRefPubMedGoogle Scholar
  20. 20.
    Schultz GS, Barillo DJ, Mozingo DW, et al. Wound bed preparation and a brief history of TIME. Int Wound J. 2004;1:19–32.CrossRefPubMedGoogle Scholar
  21. 21.
    Schultz GS, Sibbald RG, Falanga V, et al. Wound bed preparation: a systematic approach to wound management. Wound Repair Regen. 2003;11:S1–S28.CrossRefPubMedGoogle Scholar
  22. 22.
    Runkel N, Krug E, Berg L, et al. Evidence-based recommendations for the use of negative pressure wound therapy in traumatic wounds and reconstructive surgery: steps towards an international consensus. Injury. 2011;42:s1–s12.PubMedGoogle Scholar
  23. 23.
    Sibbald RG, Orsted H, Schultz GS, Coutts P, Keast D. Preparing the wound bed 2003: focus on infection and inflammation. Ostomy Wound Manag. 2003;49:23–51.Google Scholar
  24. 24.
    Nelson EA, Bell-Syer SEM. Compression for preventing recurrence of venous ulcers. Cochrane Database Syst Rev. 2014;(9):CD002303.Google Scholar
  25. 25.
    Pannier F, Rabe E. Differential diagnosis of leg ulcers. Phlebology. 2013;28(Suppl 1):55–60.CrossRefPubMedGoogle Scholar
  26. 26.
    Grey JE, Harding KG, Enoch S. Venous and arterial leg ulcers. BMJ Br Med J. 2006;332:347–50.CrossRefGoogle Scholar
  27. 27.
    Weir GR, Smart H, van Marle J, Cronje FJ. Arterial disease ulcers, part 1: clinical diagnosis and investigation. Adv Skin Wound Care. 2014;27:421–8.CrossRefPubMedGoogle Scholar
  28. 28.
    Dean S. Leg ulcers: causes and management. Aust Fam Physician. 2006;35:480–4.PubMedGoogle Scholar
  29. 29.
    Hankey GJ, Norman PE, Eikelboom JW. Medical treatment of peripheral arterial disease. JAMA. 2006;295:547–53.CrossRefPubMedGoogle Scholar
  30. 30.
    Bakker K, Schaper NC, Apelqvist J. Practical guidelines on the management and prevention of the diabetic foot 2011. Diabetes Metab Res Rev. 2012;28(Suppl 1):225–31.CrossRefPubMedGoogle Scholar
  31. 31.
    Vinik AI, Nevoret M-L, Casellini C, Parson H. Diabetic neuropathy. Endocrinol Metab Clin N Am. 2013;42:747–87.CrossRefGoogle Scholar
  32. 32.
    Nascimento OJM. Leprosy neuropathy: clinical presentations. Arq Neuropsiquiatr. 2013;71:661–6.CrossRefPubMedGoogle Scholar
  33. 33.
    Feng Y, Schlösser FJ, Sumpio BE. The Semmes Weinstein monofilament examination is a significant predictor of the risk of foot ulceration and amputation in patients with diabetes mellitus. J Vasc Surg. 2011;53:220–6.CrossRefPubMedGoogle Scholar
  34. 34.
    Frykberg RG, Zgonis T, Armstrong DG, et al. Diabetic foot disorders: a clinical practice guideline (2006 revision). J Foot Ankle Surg. 2006;45:S1–66.CrossRefPubMedGoogle Scholar
  35. 35.
    Alavi A, Sibbald RG, Mayer D, et al. Diabetic foot ulcers: Part II. Management. J Am Acad Dermatol. 2014;70:e1–21.CrossRefGoogle Scholar
  36. 36.
    Alavi A, Mayer D, Hafner J, Sibbald RG. Martorell hypertensive ischemic leg ulcer: an underdiagnosed entity. Adv Skin Wound Care. 2012;25:563–72.CrossRefPubMedGoogle Scholar
  37. 37.
    Blanco González E, Gago Vidal B, Murillo Solís D, Domingo Del Valle J. Martorell’s ulcer: an unusual complication of long-term hypertension. Hipertens Riesgo Vasc. 2011;28:211–3.CrossRefGoogle Scholar
  38. 38.
    Vuerstaek JDD, Reeder SWI, Henquet CJM, Neumann HAM. Arteriolosclerotic ulcer of Martorell. J Eur Acad Dermatol Venereol. 2010;24:867–74.CrossRefPubMedGoogle Scholar
  39. 39.
    Ruocco E, Sangiuliano S, Gravina AG, Miranda A, Nicoletti G. Pyoderma gangrenosum: an updated review. J Eur Acad Dermatol Venereol. 2009;23:1008–17.CrossRefPubMedGoogle Scholar
  40. 40.
    Panuncialman J, Falanga V. Basic approach to inflammatory ulcers. Dermatol Ther. 2006;19:365–76.CrossRefPubMedGoogle Scholar
  41. 41.
    Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA. Antiphospholipid syndrome. Lancet. 2010;376:1498–509.CrossRefGoogle Scholar
  42. 42.
    Gonzalez-Santiago TM, Davis MDP. Update of management of connective tissue diseases: livedoid vasculopathy. Dermatol Ther. 2012;25:183–94.CrossRefPubMedGoogle Scholar
  43. 43.
    Kerk N, Goerge T. Livedoid vasculopathy – current aspects of diagnosis and treatment of cutaneous infarction. J Dtsch Dermatol Ges. 2013;11:407–10.PubMedGoogle Scholar
  44. 44.
    Yesilada AK, Sevim KZ, Sucu DO, et al. Marjolin ulcer: clinical experience with 34 patients over 15 years. J Cutan Med Surg. 2013;17:404–9.Google Scholar
  45. 45.
    Pavlovic S, Wiley E, Guzman G, Morris D, Braniecki M. Marjolin ulcer: an overlooked entity. Int Wound J. 2011;8:419–24.CrossRefPubMedGoogle Scholar
  46. 46.
    Warren AG, Brorson H, Borud LJ, Slavin SA. Lymphedema: a comprehensive review. Ann Plast Surg. 2007;59(4):464–72.CrossRefPubMedGoogle Scholar
  47. 47.
    Clodius L. Lymphatics, lymphodynamics, lymphedema: an update. Plast Surg Outlook. 1990;4:1.Google Scholar
  48. 48.
    Smeltzer DM, Stickler GB, Schirger A. Primary lymphedema in children and adolescents: a follow-up study and review. Pediatrics. 1985;76:206–18.PubMedGoogle Scholar
  49. 49.
    Moffatt CJ, Franks PJ, Doherty DC, et al. Lymphoedema: an underestimated health problem. QJM. 2003;96:731–8.CrossRefPubMedGoogle Scholar
  50. 50.
    Pannier F, Hoffmann B, Stang A, Jöckel KH, Rabe E. Prevalence of Stemmer’s sign in the general population. Phlebologie. 2007;36:287–342.Google Scholar
  51. 51.
    Ruocco V, Schwartz RA, Ruocco E. Lymphedema: an immunologically vulnerable site for development of neoplasms. J Am Acad Dermatol. 2002;47:124–7.CrossRefPubMedGoogle Scholar
  52. 52.
    Thomas KS, Crook AM, Nunn AJ, et al. Penicillin to prevent recurrent leg cellulitis. N Engl J Med. 2013;368:1695–703.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2018

Authors and Affiliations

  • Luciana Patrícia Fernandes Abbade
    • 1
    Email author
  • Hélio Amante Miot
    • 1
  1. 1.Department of Dermatology, UNESPBotucatuBrazil

Personalised recommendations